ELECTROMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.77 USD | -2.53% |
|
+8.76% | +44.55% |
| Feb. 13 | Transcript : Electromed, Inc., Q2 2024 Earnings Call, Feb 13, 2024 | |
| Feb. 13 | Electromed, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Electromed First ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Calendar
2024-05-07
- Q3 2024 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.77
USD
Average target price
26
USD
Spread / Average Target
+64.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +44.55% | 136M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- ELMD Stock
- News Electromed, Inc.
- Transcript : Electromed, Inc., Q1 2024 Earnings Call, Nov 07, 2023
